ScripErasca Inc. and Imago BioSciences, Inc. raised the most money out of the five biopharmaceutical companies that launched initial public offerings during the first half of July, and their stocks were
ScripSweden-based Amniotics AB is in the early stages of developing a unique stem cell-based pipeline using amniotic fluid sourced from caesarean section births – an approach that is ethically sound and